March 11, 2024
A Boston-area biotech developer that has yet to bring a product to market persuaded the Federal Circuit on Monday to affirm a finding by an administrative patent board last year that stripped a smaller Chinese rival of a patent covering a way of using a type of sulfonic acid to potentially treat Alzheimer's disease.
July 13, 2022
A panel of Patent Trial and Appeal Board judges has sided with arguments from Boston biotech developer Alzheon Inc. that the patent office never should have granted a patent to a smaller Chinese rival that covers a way of using a type of sulfonic acid to potentially treat Alzheimer's disease.
April 07, 2022
The company behind Norton's AntiVirus brand of malware detection software has armed itself with some new BigLaw guns to defend against a nearly decade-old patent lawsuit that claims some of that software was actually developed by professors at Columbia University. Here's a look at that case — plus all the other major intellectual property matters facing the court in the coming week.
July 15, 2021
The Patent Trial and Appeal Board has agreed to review a Chinese company's patent involving a treatment for Alzheimer's disease challenged by biotech firm Alzheon Inc.